The CDC recommends a single dose of any FDA-approved RSV vaccine for all adults ages 75 years and older, as well as for 60- ...
Moderna (MRNA) was on track to see a weekly gain of 21% as of Wednesday. Shares of the vaccine maker rose 11.7% the prior day following the first reported bird flu death in the US. The stock was up as ...